• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Ménière’s Disease: A Diagnosis of Exclusion with Controversial Therapies

by Jennifer Decker Arevalo, MA • January 1, 2008

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Even though the AAO-HNS guidelines were established in 1995, they are still relevant because there hasn’t been a significant change in our understanding of the management and treatment of Ménière’s disease since then, said Dr. Megerian. Truth be told, the conservative treatment for Ménière’s disease hasn’t really changed much since the early 1900s.

You Might Also Like

  • Ménière’s Disease-Don’t Blame the Patient
  • BPPV: State of the Art in Diagnosis And Treatment
  • Intratympanic Drug Therapy Effective for Ménière’s Disease
  • Salivary Gland Malignancies: Diagnosis and Treatment of a Rare and Challenging Cancer
Explore This Issue
January 2008

All patients begin management of their disease through lifestyle and dietary changes to reduce the number of attacks. Physicians encourage their patients to avoid alcohol, caffeine, excessive fatigue, smoking, and stress, as well as to eat properly, get plenty of sleep, and remain physically active.

Figure. Hospitals are developing balance therapy programs for patients with Ménière's disease and other conditions that affect balance.

click for large version
Figure. Hospitals are developing balance therapy programs for patients with Ménière’s disease and other conditions that affect balance.

The Hydrops Diet, which involves reducing salt intake and taking a diuretic (triamterene/hydrochlorothiazide [Dyazide], amiloride/HCTZ [Moduretic], acetazolamide [Diamox]) for at least a three-month trial period, is intended to keep sodium concentrations in the inner ear from fluctuating, which causes the symptoms of hydrops. Strict adherence to a 1.5- to 2.0-gram salt diet stabilizes symptoms in most patients;2 some otolaryngologists refer patients to a dietician to help with this dietary challenge.

I also recommend that my patients drink six to eight glasses of water per day because it dilutes the sodium concentration and lowers their tendency to retain fluids, said Dr. Megerian.

Patients who present with acute, severe vertigo may be treated with vestibulosuppressants (meclizine [Antivert], lorazepam [Ativan], clonazepam [Klonapin], diazepam [Valium]) and antiemetics (promethazine [Phenergan], prochlorperazine [Compazine]), which are used on an as-needed basis, as they cause drowsiness and harm in the long term.1 Similar medications are also used in between attacks.

The majority of, if not all, ENTs agree that the treatment of Ménière’s disease begins with the Hydrops Diet and medications to mitigate or prevent symptoms, said Dr. Hoffer.

Almost 90 percent of patients are adequately managed and have resolution of their vertigo and stabilization of their hearing with this conservative treatment, added Dr. Megerian. Many well-respected otolaryngologists agree that Ménière’s disease is more a medical than a surgical disorder. Only 10 to 15 percent of patients must try further interventions, some more destructive than others, but this still represents a large number of patients.

The batting order, as to what treatments come next, is not only controversial, but dependent upon the ENT’s training, comfort level with specific therapies and geographic practice location.

In my practice, I commonly treat patients who have intractable Ménière’s disease with intratympanic gentamicin and endolymphatic sac decompression or shunt to control their vertigo, said Dr. Megerian.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Departments, Head and Neck, Medical Education, Otology/Neurotology, Practice Focus Tagged With: cancer, CT, debate, diagnosis, guidelines, hearing loss, meniere's, radiation, research, steroids, tinnitus, treatment, tumor, vertigoIssue: January 2008

You Might Also Like:

  • Ménière’s Disease-Don’t Blame the Patient
  • BPPV: State of the Art in Diagnosis And Treatment
  • Intratympanic Drug Therapy Effective for Ménière’s Disease
  • Salivary Gland Malignancies: Diagnosis and Treatment of a Rare and Challenging Cancer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939